Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
2000 Turkeys
Roads, Travel and Traffic
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Jobs
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
2000 Turkeys
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Jobs
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
CVRx, Inc. - Common Stock
Cel-Sci Corporation Common Stock
Creative Global Technology Holdings Limited - Class A Ordinary Shares
Expion Energy, Inc. - Common Stock
Gentherm Inc - Common Stock
IP Strategy Holdings, Inc. - Common Stock
KANZHUN LIMITED - American Depository Shares
Leishen Energy Holding Co., Ltd. - Class A Ordinary Shares
Lightwave Logic, Inc. - Common Stock
Mangoceuticals, Inc. - Common Stock
Microbot Medical Inc. - Common Stock
MultiSensor AI Holdings, Inc. - Common Stock
Proofpoint, Inc. - Common Stock
Ranpak Holdings Corp Class A Common Stock
ReShape Lifesciences, Inc. - Common Stock
SS Innovations International Inc. - Common Stock
Safety Insurance Group, Inc. - Common Stock
Sanara MedTech Inc. - Common Stock
Sonida Senior Living, Inc. Common Stock
VanEck Semiconductor ETF
Edit Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
CVRx, Inc. - Common Stock
(NQ:
CVRX
)
0.8687
-0.6013 (-40.90%)
Delayed Quote
Updated: 4:00 PM EST, Nov 6, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about CVRx, Inc. - Common Stock
< Previous
1
2
3
4
5
Next >
Top US Stock Gainers and Losers in Today's Session
↗
November 06, 2026
Via
Chartmill
Top US Stock Gainers and Losers: Nov. 6, 2026 Session
↗
November 06, 2026
Via
Chartmill
CVRx (CVRX) Q3 2026 Earnings Call Transcript
↗
November 06, 2026
Payer delays and specialist turnover weighed on results and guidance.
Via
The Motley Fool
Topics
Earnings
Gap Stocks in Today's Session
↗
November 06, 2026
Via
Chartmill
CVRX Inc (NASDAQ:CVRX) Q1 2026 Earnings Meet Revenue Estimates, Loss Slightly Narrower Than Expected
↗
May 11, 2026
Via
Chartmill
CVRX Inc (NASDAQ:CVRX) Reports Mixed Q4 2025 Results, Slight EPS Miss
↗
February 12, 2026
Via
Chartmill
Earnings Scheduled For November 5, 2025
↗
November 05, 2025
Via
Benzinga
Top movers analysis one hour before the close of the markets on 2026-09-30: top gainers and losers in today's session.
↗
September 30, 2026
Via
Chartmill
Let's take a look at the stocks that are in motion in today's session.
↗
September 30, 2026
Via
Chartmill
Johnson & Johnson Owns Stakes in 15 Stocks. Here's the Best of the Bunch.
↗
August 31, 2026
One of J&J's investments stands head-and-shoulders above the rest.
Via
The Motley Fool
Earnings Scheduled For August 4, 2025
↗
August 04, 2025
Via
Benzinga
These stocks have an unusual volume in today's session
↗
August 14, 2026
Via
Chartmill
CVRx (CVRX) Q2 2026 Earnings Call Transcript
↗
August 13, 2026
U.S. heart failure revenue surged 21% amid reimbursement gains and sales expansion challenges.
Via
The Motley Fool
Topics
Earnings
These stocks have an unusual volume in today's session
↗
August 13, 2026
Via
Chartmill
CVRx Eyes Barostim Growth as Coverage Gains and BENEFIT-HF Trial Launches
↗
August 13, 2026
CVRx (NASDAQ:CVRX) outlined its efforts to expand adoption of its Barostim therapy for heart failure patients, emphasizing sales-force execution, payer coverage progress and a large post-market...
Via
MarketBeat
In today's session, these stocks are experiencing unusual volume.
↗
August 10, 2026
Via
Chartmill
What's going on in today's session
↗
August 07, 2026
Via
Chartmill
Which stocks are gapping on Friday?
↗
August 07, 2026
Via
Chartmill
Top movers in Friday's pre-market session
↗
August 07, 2026
Via
Chartmill
CVRx Q2 Earnings Call Highlights
↗
August 06, 2026
CVRx (NASDAQ:CVRX) reported second-quarter revenue growth and an improved gross margin, but lowered its full-year outlook as sales-force turnover, slower productivity ramps and reimbursement challenges...
Via
MarketBeat
Topics
Earnings
Curious about the stocks that are showing activity after the closing bell on Thursday?
↗
August 06, 2026
Via
Chartmill
CVRx Q1 Earnings Call Highlights
↗
May 11, 2026
CVRx (NASDAQ:CVRX) reported first-quarter 2026 revenue of $14.8 million, up 20% from the prior-year period, as U.S. growth in its Barostim heart failure business helped the company exceed the high end...
Via
MarketBeat
Topics
Earnings
CVRx (CVRX) Q1 2026 Earnings Call Transcript
↗
May 11, 2026
CVRx (CVRX) Q1 2026 Earnings Call Transcript
Via
The Motley Fool
Topics
Earnings
Get insights into the top gainers and losers of Friday's after-hours session.
↗
February 20, 2026
Via
Chartmill
CVRx (CVRX) Q4 2025 Earnings Call Transcript
↗
February 12, 2026
CVRx (CVRX) Q4 2025 Earnings Call Transcript
Via
The Motley Fool
Topics
Earnings
CVRx (CVRX) Q3 2025 Earnings Call Transcript
↗
November 05, 2025
CVRx (CVRX) Q3 2025 Earnings Call Transcript
Via
The Motley Fool
Topics
Earnings
CVRx (CVRX) Q2 Revenue Jumps 15%
↗
August 04, 2025
Via
The Motley Fool
CVRx Inc (NASDAQ:CVRX) Reports Q2 2025 Earnings: Revenue Slightly Beats Estimates While EPS Misses
↗
August 04, 2025
CVRx reported Q2 2025 revenue of $13.59M, beating estimates, but EPS missed at -$0.57. Shares dipped slightly as losses widened despite steady Barostim commercialization.
Via
Chartmill
Top movers in Friday's session
↗
May 09, 2025
Curious about what's happening in today's session? Check out the latest stock movements and price changes.
Via
Chartmill
Keep an eye on the top gainers and losers in Friday's session.
↗
May 09, 2025
Wondering how the US markets performed in the middle of the day on Friday? Discover the movers and shakers of today's session in our comprehensive analysis.
Via
Chartmill
< Previous
1
2
3
4
5
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at
/week.
Subscribe Today